Citation 123019

MARSHALL,ME: KERVIN,K: BENEFIELD,C: UMERANI,A: ALBAINY-JENEI,S: ZHAO,Q: KHAZAELI,MB:. (1994). GROWTH-INHIBITORY EFFECTS OF COUMARIN (1,2-BENZOPYRONE) AND 7-HYDROXYCOUMARIN ON HUMAN MALIGNANT CELL LINES IN VITRO.. 120()

Citation Details

Title	GROWTH-INHIBITORY EFFECTS OF COUMARIN (1,2-BENZOPYRONE) AND 7-HYDROXYCOUMARIN ON HUMAN MALIGNANT CELL LINES IN VITRO.
Authors	MARSHALL,ME: KERVIN,K: BENEFIELD,C: UMERANI,A: ALBAINY-JENEI,S: ZHAO,Q: KHAZAELI,MB:
Year	1994
Volume	120
Issue

Summary

Year: 1994

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIN	EQUIVOCAL
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIN	EQUIVOCAL
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIN	EQUIVOCAL
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIN	EQUIVOCAL
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIN	EQUIVOCAL
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIN	EQUIVOCAL
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIN	EQUIVOCAL
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIN	EQUIVOCAL
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIN	EQUIVOCAL
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIN	EQUIVOCAL
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIN	EQUIVOCAL
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIN	EQUIVOCAL
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIN	EQUIVOCAL
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	COUMARIN	EQUIVOCAL
15	THYMIDINE INCORPORATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIN	EQUIVOCAL
16	URIDINE INCORPORATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIN	WEAK ACTIVITY
17	LEUCINE INCORPORATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIN	WEAK ACTIVITY
18	THYMIDINE INCORPORATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIN	EQUIVOCAL
19	URIDINE INCORPORATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIN	WEAK ACTIVITY
20	LEUCINE INCORPORATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMARIN	EQUIVOCAL
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	UMBELLIFERONE	EQUIVOCAL
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	UMBELLIFERONE	EQUIVOCAL
23	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	UMBELLIFERONE	EQUIVOCAL
24	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	UMBELLIFERONE	EQUIVOCAL
25	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	UMBELLIFERONE	EQUIVOCAL
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	UMBELLIFERONE	EQUIVOCAL
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	UMBELLIFERONE	EQUIVOCAL
28	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	UMBELLIFERONE	EQUIVOCAL
29	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	UMBELLIFERONE	EQUIVOCAL
30	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	UMBELLIFERONE	EQUIVOCAL
31	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	UMBELLIFERONE	EQUIVOCAL
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	UMBELLIFERONE	EQUIVOCAL
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	UMBELLIFERONE	EQUIVOCAL
34	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	UMBELLIFERONE	EQUIVOCAL
35	THYMIDINE INCORPORATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	UMBELLIFERONE	WEAK ACTIVITY
36	URIDINE INCORPORATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	UMBELLIFERONE	WEAK ACTIVITY
37	LEUCINE INCORPORATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	UMBELLIFERONE	WEAK ACTIVITY
38	THYMIDINE INCORPORATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	UMBELLIFERONE	EQUIVOCAL
39	URIDINE INCORPORATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	UMBELLIFERONE	WEAK ACTIVITY
40	LEUCINE INCORPORATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	UMBELLIFERONE	WEAK ACTIVITY
41	PSA(PROSTATE-SPECIFIC ANTIGEN) PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	UMBELLIFERONE	WEAK ACTIVITY
42	APOPTOSIS INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	UMBELLIFERONE	WEAK ACTIVITY

Citation 123019

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1